Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
American Journal of Hematology
Published October 21, 2026
Outcomes of Patients With AL Amyloidosis and End-Stage Renal Disease After Initiation of Therapy.
October 23, 2026
Medspoke
Medspoke
Blood Advances
Published October 21, 2026
00:00
--:--
Glofitamab with polatuzumab vedotin in relapsed/refractory central nervous system lymphomas.
October 23, 2026
Share
Glofitamab with polatuzumab vedotin in relapsed/refractory central nervous system lymphomas.
https://www.medspoke.co/channel_journal?id=683&tap_id=16146
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Blood Advances
Published October 21, 2026
Prospective phase 2 trial of high- and intermediate-intensity myeloablative conditioning for cord...
October 23, 2026
Why are you reporting this TALK?
